Showing results (1-10 of 146) with videos related to
Sort By:
Pageof 15
Nuclear Medicine and Molecular Imaging|December 21, 2016
Systemic Immune Response to Vaccination on FDG-PET/CTMark Mingos, Stephanie Howard, Nicholas Giacalone, et al.Otolaryngologic Clinics of North America|June 1, 2010
Imaging of parathyroid glandsDavid Chien, Heather JaceneJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2024
The Current and Future Roles of Precision Oncology in Advanced Breast CancerHeather Jacene, Eric Dietsche, Jennifer SpechtSeminars in Nuclear Medicine|December 3, 2017
PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-upShawn Karls, Hina Shah, Heather JaceneAnnals of Nuclear Medicine|July 13, 2019
No delayed imaging or CCK administration is needed in most cases when bowel excretion does not occur but gallbladder fills promptlyHyung Jin Choi, Heather Jacene, Chun K KimClinical Nuclear Medicine|November 27, 2008
Conversion of FDG PET activity of fibrous dysplasia of the skull late in life mimicking metastatic diseaseDavid Bonekamp, Heather Jacene, Detlef Bartelt, et al.Expert Review of Anticancer Therapy|October 28, 2022
Lutetium Lu 177 vipivotide tetraxetan for metastatic castration-resistant prostate cancerHina Shah, Praful Ravi, Guru Sonpavde, et al.FEBS Letters|November 25, 2003
Aquaporin water channels: molecular mechanisms for human diseasesPeter Agre, David KozonoClinical Genitourinary Cancer|April 22, 2018
Hematologic Toxicity From Radium-223 Therapy for Bone Metastases in Castration-Resistant Prostate Cancer: Risk Factors and Practical ConsiderationsHeather Jacene, Leonard Gomella, Evan Y Yu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2009
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumorsRichard L Wahl, Heather Jacene, Yvette Kasamon, et al.Pageof 15